The expression of HIF-1α was specifically diminished by silencing Notch1 signaling with GSI treatment, whereas inhibiting gap junctions, integrins, or ICAM-1/E-selectin in GBM cells had no effect. The gene discussed is ICAM1; the disease is glioblastoma.